Svenska Aerogel announces the outcome of the exercise of warrants of series TO9

Svenska Aerogel Holding AB (publ) (”Svenska Aerogel” or the “Company") announces today the outcome of the exercise of the warrants of series TO9 that were issued in connection with the Company’s rights issue of units in spring 2026 (”TO9” or the “Warrants”). A total of 3,797,391 Warrants were exercised, corresponding to approximately 38.4 per cent of the outstanding TO9, for subscription of 3,797,391 shares at a subscription price of SEK 0.93 per share. Through the exercise of the Warrants, Svenska Aerogel will receive approximately SEK 3.5 million before issue costs.

Comment from Tor Einar Norbakk, CEO

“I would like to thank our shareholders, Board of Directors and management team for their continued support. With a stronger financial position, we can continue to advance our commercialization efforts with a clear focus on growing sales.”

Background

The exercise period for the Warrants ran from 11 September 2026 up to and including 25 September 2026. The subscription price per share upon exercise of the Warrants amounted to SEK 0.93.

A total of 3,797,391 Warrants were exercised for subscription of 3,797,391 shares, which means that approximately 38.4 per cent of the outstanding Warrants were exercised for subscription of shares. Through the exercise of the Warrants, Svenska Aerogel will receive approximately SEK 3.5 million before issue costs.

The exercised TO9 have been replaced with interim shares (IA) pending registration with the Swedish Companies Registration Office (Bolagsverket). The conversion of interim shares to shares is expected to take place within three (3) weeks.

Number of shares, share capital and dilution

Through the exercise of the Warrants, the number of shares in Svenska Aerogel will increase by 3,797,391 shares, from 49,501,067 shares to 53,298,458 shares. The share capital will increase by SEK 227,843.46, from SEK 2,970,064.02 to SEK 3,197,907.48.

For existing shareholders who have not exercised Warrants for subscription of new shares, the dilution amounts to approximately 7.1 percent of the number of shares and votes in the Company.

Advisers
Aqurat Fondkommission AB is acting as issuing agent for Svenska Aerogel in connection with the exercise of TO9. Eversheds Sutherland Advokatbyrå AB is acting as legal adviser to the Company in connection with the exercise of TO9.

For further information, please contact:
Tor Einar Norbakk, CEO.
Telephone: +46 (0)70 616 08 67.
E-mail: toreinar.norbakk@aerogel.se

About Svenska Aerogel Holding AB (publ)
Svenska Aerogel manufactures and commercializes the mesoporous material Naerogel^®. Svenska Aerogel's business concept is to meet the market’s need for new materials that are in line with global sustainability objectives. Naerogel^® is flexible and can be tailored to different applications to add essential properties to an end product. The company's vision is to be the most valued business partner providing pioneering material solutions for a sustainable world.
Svenska Aerogel Holding AB is listed on Nasdaq First North Growth Market. Certified Adviser is FNCA.
Subscribe to Svenska Aerogel’s press releases: aerogel.se